Invention Grant
- Patent Title: Prevention and treatment of mycobacterium infection
-
Application No.: US14367854Application Date: 2012-12-20
-
Publication No.: US09610337B2Publication Date: 2017-04-04
- Inventor: James Anthony Triccas , Rachel Pinto-Nadanachandran , Warwick John Britton
- Applicant: The University of Sydney , CENTENARY INSTITUTE OF CANCER MEDICINE AND CELL BIOLOGY
- Applicant Address: AU New South Wales
- Assignee: The University of Sydney Centenary Institute of Cancer Medicine and Cell Biology
- Current Assignee: The University of Sydney Centenary Institute of Cancer Medicine and Cell Biology
- Current Assignee Address: AU New South Wales
- Agency: Bozicevic, Field & Francis LLP
- Agent Edward J. Baba; Khin K. Chin
- International Application: PCT/AU2012/001569 WO 20121220
- International Announcement: WO2013/091004 WO 20130627
- Main IPC: A61K39/04
- IPC: A61K39/04 ; C07K14/35 ; C12N9/12 ; A61K38/00 ; A61K39/00
Abstract:
The invention relates to the identification of antigens, including Mycobacterium sulphate assimilation pathway components such as CysD, for preventing and treating Mycobacterium infection, especially but not exclusively Mycobacterium tuberculosis infection; to expression systems including live Mycobacterium for expression of said antigens for prevention and treatment of said infection; and to use of said antigens and expression systems for prevention and treatment of said infection.
Public/Granted literature
- US20160022795A1 Prevention and Treatment of Mycobacterium Infection Public/Granted day:2016-01-28
Information query
